scispace - formally typeset
M

María-Carmen López de Las Hazas

Researcher at IMDEA

Publications -  42
Citations -  1102

María-Carmen López de Las Hazas is an academic researcher from IMDEA. The author has contributed to research in topics: Hydroxytyrosol & Medicine. The author has an hindex of 14, co-authored 31 publications receiving 567 citations. Previous affiliations of María-Carmen López de Las Hazas include University of Lleida & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

Differential absorption and metabolism of hydroxytyrosol and its precursors oleuropein and secoiridoids

TL;DR: Findings suggest that OLE might be the most suitable precursor of HT for incorporation into foods or nutraceutical formulations and bioavailability based on the urine excretion of HT metabolites was higher.
Journal ArticleDOI

Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy.

TL;DR: In this paper, exosomes were isolated from raw bovine milk, combining ultracentrifugation and size exclusion chromatography (SEC) methodology, and then loaded with exogenous hsa-miR148a-3p, a highly expressed miRNA in milk exosome.
Journal ArticleDOI

Protective effect of hydroxytyrosol and its predominant plasmatic human metabolites against endothelial dysfunction in human aortic endothelial cells

TL;DR: Physiological HT metabolites, synthetized for the first time by using an intestinal cell model, might be responsible in part for the protection against endothelial dysfunction.
Journal ArticleDOI

Hydroxytyrosol and the Colonic Metabolites Derived from Virgin Olive Oil Intake Induce Cell Cycle Arrest and Apoptosis in Colon Cancer Cells

TL;DR: Results showed that HT and phenylacetic and hydroxyphenylpropionic acids produce cell cycle arrest and promote apoptosis and HT-29 cells were more sensitive to phenol treatments than Caco-2.